No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Benzenesulfonates / therapeutic use*
-
Carcinoma, Hepatocellular / drug therapy*
-
Drug Approval
-
Humans
-
Liver Neoplasms / drug therapy*
-
Niacinamide / analogs & derivatives
-
Phenylurea Compounds
-
Protein-Tyrosine Kinases / antagonists & inhibitors
-
Pyridines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Sorafenib
-
United States
-
United States Food and Drug Administration*
Substances
-
Antineoplastic Agents
-
Benzenesulfonates
-
Phenylurea Compounds
-
Pyridines
-
Niacinamide
-
Sorafenib
-
Protein-Tyrosine Kinases